Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120699211> ?p ?o ?g. }
- W3120699211 endingPage "740" @default.
- W3120699211 startingPage "719" @default.
- W3120699211 abstract "Phenotypic screening of a Medicines for Malaria Venture compound library against Mycobacterium tuberculosis (Mtb) identified a cluster of pan-active 2-pyrazolylpyrimidinones. The biology triage of these actives using various tool strains of Mtb suggested a novel mechanism of action. The compounds were bactericidal against replicating Mtb and retained potency against clinical isolates of Mtb. Although selected MmpL3 mutant strains of Mtb showed resistance to these compounds, there was no shift in the minimum inhibitory concentration (MIC) against a mmpL3 hypomorph, suggesting mutations in MmpL3 as a possible resistance mechanism for the compounds but not necessarily as the target. RNA transcriptional profiling and the checkerboard board 2D-MIC assay in the presence of varying concentrations of ferrous salt indicated perturbation of the Fe-homeostasis by the compounds. Structure-activity relationship studies identified potent compounds with good physicochemical properties and in vitro microsomal metabolic stability with moderate selectivity over cytotoxicity against mammalian cell lines." @default.
- W3120699211 created "2021-01-18" @default.
- W3120699211 creator A5001793138 @default.
- W3120699211 creator A5009835769 @default.
- W3120699211 creator A5014913712 @default.
- W3120699211 creator A5015718793 @default.
- W3120699211 creator A5017031079 @default.
- W3120699211 creator A5017389980 @default.
- W3120699211 creator A5023695413 @default.
- W3120699211 creator A5026225819 @default.
- W3120699211 creator A5027146217 @default.
- W3120699211 creator A5027471457 @default.
- W3120699211 creator A5028450220 @default.
- W3120699211 creator A5033369594 @default.
- W3120699211 creator A5034087952 @default.
- W3120699211 creator A5036429812 @default.
- W3120699211 creator A5036576811 @default.
- W3120699211 creator A5036821179 @default.
- W3120699211 creator A5038580723 @default.
- W3120699211 creator A5040396237 @default.
- W3120699211 creator A5043648393 @default.
- W3120699211 creator A5058976402 @default.
- W3120699211 creator A5061592542 @default.
- W3120699211 creator A5071262153 @default.
- W3120699211 creator A5072040245 @default.
- W3120699211 creator A5080058098 @default.
- W3120699211 creator A5085312013 @default.
- W3120699211 creator A5090828975 @default.
- W3120699211 date "2021-01-04" @default.
- W3120699211 modified "2023-10-16" @default.
- W3120699211 title "Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies" @default.
- W3120699211 cites W1895410967 @default.
- W3120699211 cites W1898374751 @default.
- W3120699211 cites W1959882791 @default.
- W3120699211 cites W1965401945 @default.
- W3120699211 cites W1974305305 @default.
- W3120699211 cites W1982065633 @default.
- W3120699211 cites W2004361822 @default.
- W3120699211 cites W2007175531 @default.
- W3120699211 cites W2011915196 @default.
- W3120699211 cites W2026463978 @default.
- W3120699211 cites W2043250954 @default.
- W3120699211 cites W2046433061 @default.
- W3120699211 cites W2057740405 @default.
- W3120699211 cites W2063471616 @default.
- W3120699211 cites W2067576392 @default.
- W3120699211 cites W2068164634 @default.
- W3120699211 cites W2071932302 @default.
- W3120699211 cites W2088316319 @default.
- W3120699211 cites W2095318368 @default.
- W3120699211 cites W2121303776 @default.
- W3120699211 cites W2128482141 @default.
- W3120699211 cites W2131590361 @default.
- W3120699211 cites W2140286346 @default.
- W3120699211 cites W2153165208 @default.
- W3120699211 cites W2158023121 @default.
- W3120699211 cites W2160400589 @default.
- W3120699211 cites W2164288361 @default.
- W3120699211 cites W2168832175 @default.
- W3120699211 cites W2170930327 @default.
- W3120699211 cites W2394814166 @default.
- W3120699211 cites W2511017471 @default.
- W3120699211 cites W2511177309 @default.
- W3120699211 cites W2574984917 @default.
- W3120699211 cites W2588796969 @default.
- W3120699211 cites W2610185685 @default.
- W3120699211 cites W2610373986 @default.
- W3120699211 cites W2733624112 @default.
- W3120699211 cites W2742048522 @default.
- W3120699211 cites W2749691721 @default.
- W3120699211 cites W2770737132 @default.
- W3120699211 cites W2913867994 @default.
- W3120699211 cites W2950122219 @default.
- W3120699211 cites W2951126183 @default.
- W3120699211 cites W2951352649 @default.
- W3120699211 cites W2951775590 @default.
- W3120699211 cites W2953076657 @default.
- W3120699211 cites W2953342335 @default.
- W3120699211 cites W4233123422 @default.
- W3120699211 cites W72847820 @default.
- W3120699211 doi "https://doi.org/10.1021/acs.jmedchem.0c01727" @default.
- W3120699211 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7816196" @default.
- W3120699211 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33395287" @default.
- W3120699211 hasPublicationYear "2021" @default.
- W3120699211 type Work @default.
- W3120699211 sameAs 3120699211 @default.
- W3120699211 citedByCount "8" @default.
- W3120699211 countsByYear W31206992112021 @default.
- W3120699211 countsByYear W31206992112022 @default.
- W3120699211 countsByYear W31206992112023 @default.
- W3120699211 crossrefType "journal-article" @default.
- W3120699211 hasAuthorship W3120699211A5001793138 @default.
- W3120699211 hasAuthorship W3120699211A5009835769 @default.
- W3120699211 hasAuthorship W3120699211A5014913712 @default.
- W3120699211 hasAuthorship W3120699211A5015718793 @default.
- W3120699211 hasAuthorship W3120699211A5017031079 @default.
- W3120699211 hasAuthorship W3120699211A5017389980 @default.
- W3120699211 hasAuthorship W3120699211A5023695413 @default.